{"id":"W4379467566","doi":"10.1016/s2468-1253(23)00141-3","title":"Performance of non-invasive tests and histology for the prediction of clinical outcomes in patients with non-alcoholic fatty liver disease: an individual participant data meta-analysis","year":2023,"lang":"en","type":"review","venue":"˜The œLancet. Gastroenterology & hepatology","topic":"Liver Disease Diagnosis and Treatment","field":"Medicine","cited_by":187,"is_retracted":false,"has_abstract":true,"ca_institutions":"McGill University Health Centre","funders":"Novartis Pharma; Julius Clinical; Ipsen; Novo Nordisk; Eisai; University of Nottingham; Innovative Medicines Initiative; Novo Nordisk Fonden; Newcastle University; Korea Health Industry Development Institute; Abbott Laboratories; CSL Behring; National Institute for Health and Care Research; NIHR Newcastle Biomedical Research Centre; Innovative Health Initiative; Amryt Pharma; Royal Society; Fonds de Recherche du Québec - Santé; Intercept Pharmaceuticals; Eli Lilly and Company; Allergan; AstraZeneca; Wellcome Trust; Alexion Pharmaceuticals; Servier; Gilead Sciences; GlaxoSmithKline; NGM Biopharmaceuticals; Kowa Company; Inventiva Pharma; Pfizer; European Federation of Pharmaceutical Industries and Associations; Sanofi; Ministry of Health and Welfare","keywords":"Medicine; Internal medicine; Cirrhosis; Gastroenterology; Fatty liver; Transient elastography; Steatohepatitis; Clinical endpoint; Hepatic encephalopathy; Liver disease; Ascites; Stage (stratigraphy); Clinical trial; Disease; Liver fibrosis","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":["metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.02912821,0.003103675,0.01710739,0.003346846,0.0007020593,0.003582026,0.002985509,0.003029524,0.002323887],"category_scores_gemma":[0.05215618,0.001549554,0.06108117,0.003876776,0.0008442686,0.001877659,0.001840487,0.002783912,0.0003583849],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001359207,"about_ca_system_score_gemma":0.001538762,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.003847261,"about_ca_topic_score_gemma":0.005869919,"domain_scores_codex":[0.9784388,0.0143458,0.00282094,0.002695102,0.001211615,0.000487777],"domain_scores_gemma":[0.9552319,0.03537192,0.004252392,0.002877043,0.001781835,0.0004848882],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","study_design_scores_codex":[0.005112271,0.00002223214,0.01047121,0.0209558,0.9597287,0.00006990668,0.00003814843,0.0005709983,0.0001677998,0.00004738331,0.0002226994,0.0025929],"study_design_scores_gemma":[0.0006920467,0.0002369916,0.004254624,0.001082929,0.9927441,0.00004935179,0.00001355778,0.0003675569,0.00007865018,0.0001308867,0.0003336758,0.00001576955],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.06619684,0.9234607,0.005209567,0.0005902614,0.000557148,0.0005175418,0.00256402,0.0001735623,0.0007304746],"genre_scores_gemma":[0.8732301,0.1138844,0.005964209,0.001340997,0.0005118586,0.001643975,0.002641309,0.000136673,0.0006464737],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9828926,"threshold_uncertainty_score":0.1540465,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.333963645560395,"score_gpt":0.4189293496940114,"score_spread":0.08496570413361643,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}